Recombinant Human FRG1 Protein，GST

FRG1, or Farnesylated Rab GTPase 1, is a protein that has gained attention in recent years due to its association with certain biological processes and diseases. Initially identified in studies related to muscle development and function, FRG1 is believed to play a crucial role in signaling pathways that govern cell growth, differentiation, and survival. Research indicates that mutations or dysregulation of FRG1 may contribute to pathological conditions, particularly in neuromuscular disorders such as facioscapulohumeral muscular dystrophy (FSHD). The exploration of FRG1 as a recombinant protein has opened avenues for understanding its structure-function relationships, interaction with other cellular components, and its potential role in therapeutic interventions. By utilizing techniques in protein engineering and molecular biology, researchers aim to elucidate the mechanistic underpinnings of FRG1's action, providing insights that could lead to novel treatments for diseases linked to its dysfunction. The recombinant expression of FRG1 also enables the development of high-throughput screening assays, facilitating the discovery of small molecules or biologics that may modulate its activity. As the scientific community continues to uncover the complexities surrounding FRG1, its significance in both basic research and clinical applications becomes increasingly evident, marking it as a critical focus in the field of molecular biology and medicine.